325 related articles for article (PubMed ID: 23410987)
1. Enhanced transcutaneous immunization via dissolving microneedle array loaded with liposome encapsulated antigen and adjuvant.
Guo L; Chen J; Qiu Y; Zhang S; Xu B; Gao Y
Int J Pharm; 2013 Apr; 447(1-2):22-30. PubMed ID: 23410987
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant effect of cationic liposomes and CpG depends on administration route.
Slütter B; Bal SM; Ding Z; Jiskoot W; Bouwstra JA
J Control Release; 2011 Sep; 154(2):123-30. PubMed ID: 21315779
[TBL] [Abstract][Full Text] [Related]
3. A fast-dissolving microneedle array loaded with chitosan nanoparticles to evoke systemic immune responses in mice.
Li Z; He Y; Deng L; Zhang ZR; Lin Y
J Mater Chem B; 2020 Jan; 8(2):216-225. PubMed ID: 31803892
[TBL] [Abstract][Full Text] [Related]
4. DNA-based vaccination against hepatitis B virus using dissolving microneedle arrays adjuvanted by cationic liposomes and CpG ODN.
Qiu Y; Guo L; Zhang S; Xu B; Gao Y; Hu Y; Hou J; Bai B; Shen H; Mao P
Drug Deliv; 2016 Sep; 23(7):2391-2398. PubMed ID: 25625495
[TBL] [Abstract][Full Text] [Related]
5. Co-encapsulation of antigen and Toll-like receptor ligand in cationic liposomes affects the quality of the immune response in mice after intradermal vaccination.
Bal SM; Hortensius S; Ding Z; Jiskoot W; Bouwstra JA
Vaccine; 2011 Jan; 29(5):1045-52. PubMed ID: 21129393
[TBL] [Abstract][Full Text] [Related]
6. Co-encapsulation of an antigen and CpG oligonucleotides into PLGA microparticles by TROMS technology.
San Román B; Irache JM; Gómez S; Tsapis N; Gamazo C; Espuelas MS
Eur J Pharm Biopharm; 2008 Sep; 70(1):98-108. PubMed ID: 18501572
[TBL] [Abstract][Full Text] [Related]
7. Enhanced immunization via dissolving microneedle array-based delivery system incorporating subunit vaccine and saponin adjuvant.
Zhao JH; Zhang QB; Liu B; Piao XH; Yan YL; Hu XG; Zhou K; Zhang YT; Feng NP
Int J Nanomedicine; 2017; 12():4763-4772. PubMed ID: 28740383
[TBL] [Abstract][Full Text] [Related]
8. Attachment of class B CpG ODN onto DOTAP/DC-chol liposome in nasal vaccine formulations augments antigen-specific immune responses in mice.
Tada R; Muto S; Iwata T; Hidaka A; Kiyono H; Kunisawa J; Aramaki Y
BMC Res Notes; 2017 Jan; 10(1):68. PubMed ID: 28126014
[TBL] [Abstract][Full Text] [Related]
9. Intradermal vaccination with hollow microneedles: A comparative study of various protein antigen and adjuvant encapsulated nanoparticles.
Du G; Hathout RM; Nasr M; Nejadnik MR; Tu J; Koning RI; Koster AJ; Slütter B; Kros A; Jiskoot W; Bouwstra JA; Mönkäre J
J Control Release; 2017 Nov; 266():109-118. PubMed ID: 28943194
[TBL] [Abstract][Full Text] [Related]
10. Effective transcutaneous immunization by antigen-loaded flexible liposome in vivo.
Li N; Peng LH; Chen X; Nakagawa S; Gao JQ
Int J Nanomedicine; 2011; 6():3241-50. PubMed ID: 22228992
[TBL] [Abstract][Full Text] [Related]
11. Orally administered OVA/CpG-ODN induces specific mucosal and systemic immune response in young and aged mice.
Alignani D; Maletto B; Liscovsky M; Rópolo A; Morón G; Pistoresi-Palencia MC
J Leukoc Biol; 2005 Jun; 77(6):898-905. PubMed ID: 15758079
[TBL] [Abstract][Full Text] [Related]
12. A low-invasive and effective transcutaneous immunization system using a novel dissolving microneedle array for soluble and particulate antigens.
Matsuo K; Yokota Y; Zhai Y; Quan YS; Kamiyama F; Mukai Y; Okada N; Nakagawa S
J Control Release; 2012 Jul; 161(1):10-7. PubMed ID: 22306332
[TBL] [Abstract][Full Text] [Related]
13. Self-assembling CpG DNA nanoparticles for efficient antigen delivery and immunostimulation.
Rattanakiat S; Nishikawa M; Takakura Y
Eur J Pharm Sci; 2012 Sep; 47(2):352-8. PubMed ID: 22771546
[TBL] [Abstract][Full Text] [Related]
14. Intradermal delivery of vaccine nanoparticles using hollow microneedle array generates enhanced and balanced immune response.
Niu L; Chu LY; Burton SA; Hansen KJ; Panyam J
J Control Release; 2019 Jan; 294():268-278. PubMed ID: 30572036
[TBL] [Abstract][Full Text] [Related]
15. Stable assemblies of cationic bilayer fragments and CpG oligonucleotide with enhanced immunoadjuvant activity in vivo.
Rozenfeld JH; Silva SR; Ranéia PA; Faquim-Mauro E; Carmona-Ribeiro AM
J Control Release; 2012 Jun; 160(2):367-73. PubMed ID: 22036878
[TBL] [Abstract][Full Text] [Related]
16. Adjuvanted, antigen loaded N-trimethyl chitosan nanoparticles for nasal and intradermal vaccination: adjuvant- and site-dependent immunogenicity in mice.
Bal SM; Slütter B; Verheul R; Bouwstra JA; Jiskoot W
Eur J Pharm Sci; 2012 Mar; 45(4):475-81. PubMed ID: 22009113
[TBL] [Abstract][Full Text] [Related]
17. Transdermal immunization using solid-in-oil nanodispersion with CpG oligodeoxynucleotide adjuvants.
Kitaoka M; Naritomi A; Hirakawa Y; Kamiya N; Goto M
Pharm Res; 2015 Apr; 32(4):1486-92. PubMed ID: 25361868
[TBL] [Abstract][Full Text] [Related]
18. Effect of sublingual administration with a native or denatured protein allergen and adjuvant CpG oligodeoxynucleotides or cholera toxin on systemic T(H)2 immune responses and mucosal immunity in mice.
Huang CF; Wang CC; Wu TC; Chu CH; Peng HJ
Ann Allergy Asthma Immunol; 2007 Nov; 99(5):443-52. PubMed ID: 18051215
[TBL] [Abstract][Full Text] [Related]
19. Time course study of the antigen-specific immune response to a PLGA microparticle vaccine formulation.
Wang Q; Tan MT; Keegan BP; Barry MA; Heffernan MJ
Biomaterials; 2014 Sep; 35(29):8385-93. PubMed ID: 24986256
[TBL] [Abstract][Full Text] [Related]
20. Co-delivery of ovalbumin and CpG motifs into microparticles protected sensitized mice from anaphylaxis.
San Román B; Irache JM; Gómez S; Gamazo C; Espuelas S
Int Arch Allergy Immunol; 2009; 149(2):111-8. PubMed ID: 19127067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
